Suppr超能文献

评估威尔巴格干预措施在精神分裂症患者中的应用:一项试点研究。

Evaluating the use of the wilbarger intervention with schizophrenic patients: a pilot study.

作者信息

Withersty David J, Stout Janet, Mogge Neil L, Nesland Anita, David Allen G

机构信息

Dr. Withersty is from William R. Sharpe Jr. Hospital and is Professor at West Virginia University School of Medicine in Morgantown, West Virginia.

出版信息

Psychiatry (Edgmont). 2005 Jan;2(1):47-9.

Abstract

Individuals with schizophrenia have difficulty processing sensory information. The authors hypothesized that the Wilbarger intervention, an occupational therapy technique successfully used to treat children with sensory integration deficits, might prove beneficial if used with schizophrenic patients. Thirty inpatients diagnosed with schizophrenia or schizoaffective disorders voluntarily participated. Each was evaluated using the sensory integration subscale of the Neurological Evaluation Scale (NES) both pre- and post-intervention. The Wilbarger was scheduled to be administered five times per day for seven days per week for four weeks. Participants averaged 19.5 days (mean) in the study (median=27.5 days) and received 80.4 (mean) (106.5 median) interventions.Those receiving 90 or more interventions improved significantly on the graphesthesia subtest (t(28)=2.498; p<0.019), the right/left confusion subtest (t(28)=2.373; p<0.025) and the post-total score (t(28)=2.184; p<0.037). Sensory subscales of the NES statistically improved after use of the Wilbarger intervention. Further studies are planned to determine the duration and clinical significance of the noted changes.

摘要

精神分裂症患者在处理感觉信息方面存在困难。作者推测,威尔巴格疗法(一种成功用于治疗有感觉统合缺陷儿童的职业治疗技术)若用于精神分裂症患者可能会有益处。30名被诊断为精神分裂症或分裂情感性障碍的住院患者自愿参与。每位患者在干预前后均使用神经评估量表(NES)的感觉统合分量表进行评估。威尔巴格疗法计划每周7天、每天进行5次,共持续4周。参与者在研究中的平均时间为19.5天(均值)(中位数 = 27.5天),接受了80.4次(均值)(中位数 = 106.5次)干预。接受90次或更多干预的患者在图形觉子测试(t(28)=2.498;p<0.019)、左右辨别错误子测试(t(28)=2.373;p<0.025)和总分后测(t(28)=2.184;p<0.037)上有显著改善。使用威尔巴格疗法后,NES的感觉分量表在统计学上有所改善。计划进一步开展研究以确定上述变化的持续时间和临床意义。

相似文献

3
Erratum.勘误
Mult Scler. 2016 Oct;22(12):NP9-NP11. doi: 10.1177/1352458515585718. Epub 2015 Jun 3.
4
The changes of biological markers and treatment efficacy in schizophrenia.精神分裂症中生物标志物的变化及治疗效果
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):323-35. doi: 10.1016/s0278-5846(00)00164-0.
6
Neurological Soft Signs and Corpus Callosum morphology in schizophrenia.精神分裂症的神经软体征与胼胝体形态。
Neurosci Lett. 2011 Jul 25;499(3):170-4. doi: 10.1016/j.neulet.2011.05.046. Epub 2011 May 27.
10
Neurological soft signs in schizophrenic patients with obsessive-compulsive disorder.
Psychiatry Clin Neurosci. 2004 Jun;58(3):274-9. doi: 10.1111/j.1440-1819.2004.01231.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验